Patents Assigned to ALACRIS THERANOSTICS GMBH
  • Publication number: 20160355878
    Abstract: The idea of this invention is to prepare ordered oligonucleotides arrays from two or more pre-synthesized shorter parts—block-synthesis approach. The parts are linked together enzymatically to form a full-length oligonucleotide of a desired sequence. Such an approach allows splitting the oligonucleotide sequences into common and unique parts. It gives the possibility to place the functional group on a common part and to minimize the length of the unique parts. Method of the invention allows combinatorial synthesis of position-specific regions. Using combinatorial approach, position-specific regions are generated by linking two or more unique oligonucleotides, so that just few said unique oligonucleotides give rise to a large variety of codes, for example, 10 unique oligonucleotides linked pairwise can produce 100 position-specific regions.
    Type: Application
    Filed: December 8, 2014
    Publication date: December 8, 2016
    Applicants: Alacris Theranostics GMBH, Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V.
    Inventors: Hans LEHRACH, Tatjana BORODINA, Vera RYKALINA
  • Publication number: 20160259918
    Abstract: The present invention relates to a method for identifying a therapeutic drug combination against a cancer, wherein the cancer comprises at least two alterations in at least two different, but crosstalking signaling pathways, the method comprising the steps of: a) providing a kinetic model of a biological network for said cancer comprising the at least two different, but crosstalking signaling pathways, wherein the kinetic model is generated by choosing a network topology, wherein the nodes of said topology represent biological entities selected from the group comprising genes, transcripts, peptides, proteins, protein modification states, small molecules, complexes, metabolites and modifications thereof, and the edges of said topology represent interactions between said entities, assigning kinetic laws and kinetic constants to the interactions and assigning concentrations to the biological entities, such that the kinetic model reflects the genome, epi-genome, proteome and/or transcriptome of said cancer, b)sel
    Type: Application
    Filed: October 6, 2014
    Publication date: September 8, 2016
    Applicant: ALACRIS THERANOSTICS GMBH
    Inventors: Alexander KÜHN, Bodo LANGE, Svetlana PEYCHEVA, Hans LEHRACH, Christoph WIERLING
  • Publication number: 20150159208
    Abstract: The present invention relates to determining pyrophosphate by electrochemical means via the depletion of metal ions as a result of its binding to and/or precipitation with pyrophosphate. This principle is of particular interest for polymerase catalysed reactions such as nucleic acid sequencing.
    Type: Application
    Filed: May 8, 2013
    Publication date: June 11, 2015
    Applicant: ALACRIS THERANOSTICS GMBH
    Inventors: Jörn Glökler, Fred Lisdat